Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04735835 · ClinicalTrials.gov registry record · NA
Personalized Responses to Dietary Composition Trial 3
A NA study of Healthy and Obesity, sponsored by Zoe Global Limited.
- Recruiting
- Registry status
- NA
- Development phase
- 250,000
- Enrollment target
- 2
- Study locations
NCT04735835: Recruiting NA study of Healthy and Obesity, sponsored by Zoe Global Limited.
NCT04735835 is a NA study of Healthy and Obesity that is actively recruiting participants, run by Zoe Global Limited. The registered enrollment target is 250,000 participants, above the 418-participant average among 1,090 other Healthy trials with a reported enrollment target (59709% higher). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04735835, a NA study of Healthy and Obesity, is actively recruiting participants, sponsored by Zoe Global Limited.
- RECRUITING
- Registry status
- NA
- Development phase
- 250,000 participants
- Enrollment target
- 2
- Study locations
Study Summary
The PREDICT 3 study will build on previous research in over 2,000 individuals to further refine machine learning models that predict individual responses to foods, with the aim of advancing precision nutrition science and individualized dietary advice. The study incorporates both standardized and controlled dietary intervention, for the purpose of testing postprandial responses to specific mixed meals, in addition to a free-living period with a dietary record for measuring responses to a large variety of meals consumed in a realistic context, where the role of external factors (e.g. exercise, sleep, time of day) on postprandial responses may be determined. For the first time this PREDICT study is built on top of a commercial product which will allow access to a much larger group of participants who are already collecting large amounts of data through digital and biochemical devices that can contribute to science.
Primary Outcome
Measurement of blood glucose by continuous glucose monitor (mmol/L)
Conditions Studied
Interventions
- OTHER Dietary Intervention
Study Locations (2)
Massachusetts
- Zoe US Inc. - Needham
Other
- King's College London - London
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 250,000 participants |
| Start Date | 2020-07-20 |
| Est. Completion | 2030-01-01 |
| Phase | NA |
What NCT04735835 shows while recruiting
NCT04735835 is an interventional study that assigns participants to a tested intervention. Its 250,000 participants enrollment target places it among the larger protocols in the corpus, above the 418-participant average among 1,090 other Healthy trials with a reported enrollment target (59709% higher).
The record links to 8 conditions, with Healthy appearing as the primary indexed condition, and to 1 intervention - of which Dietary Intervention is the first listed.
NCT04735835 reports a single indexed study location in Massachusetts, Other.
Frequently Asked Questions
What is clinical trial NCT04735835 about?
NCT04735835 is a clinical study titled "Personalized Responses to Dietary Composition Trial 3". The PREDICT 3 study will build on previous research in over 2,000 individuals to further refine machine learning models that predict individual responses to foods, with the aim of advancing precision nutrition science and individualized dietary advice. The study incorporates both standardized and co...
What is the current status of trial NCT04735835?
This trial is currently recruiting. It is a NA study. The enrollment target is 250,000 participants. The study started on 2020-07-20. Estimated completion is 2030-01-01.
What conditions does trial NCT04735835 study?
This clinical trial studies the following conditions: Healthy, Obesity, Diabetes, Heart Diseases, Diet Habit.
What interventions are being tested in trial NCT04735835?
The interventions under investigation include: Dietary Intervention (OTHER).
Who is sponsoring clinical trial NCT04735835?
This trial is sponsored by Zoe Global Limited, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04735835 being conducted?
This trial has 2 study locations across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Healthy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04735835's enrollment target sits among peer trials
250,000 1st of 1090 higher than 1,090 of 1,090 other Healthy trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Healthy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Neuromodulation-assisted Ego-disengagement: The NEURO-EGO Study Stage 1
RECRUITING · NA
-
Oxalate and Citrate in Humans - Response to Citrate
RECRUITING · NA
-
CArdioMEtabolic Function and Reserve Capacity in Healthy Adults: The CAMERA Study
RECRUITING · NA
-
Examining Bronchial Hyperresponsiveness in Primary Ciliary Dyskinesia
RECRUITING · NA
-
Medical Illustration Design Characteristic Evaluation
RECRUITING · NA
-
Sodium vs Potassium Education to Improve Vascular Health
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02280733 · 300,000 participants
A Real-World Registry of Chronic Wounds and Ulcers
- NCT06694181 · 300,000 participants
Safe and Explainable AI
- NCT07314697 · 300,000 participants · NA
Arrival Time Implementation
- NCT05365048 · 301,201 participants · NA
Provider Recommendation and HPV Vaccination
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI